Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/127709
Title: | Neuroprotective effects of the multitarget agent AVCRI104P3 in brain of middle-aged mice |
Author: | Relat, Julia Come, Julio Perez, B. Camps García, Pelayo Muñoz-Torrero López-Ibarra, Diego Badia, Albert Giménez Llort, Lydia Clos, Victòria |
Keywords: | Apoptosi Ratolins (Animals de laboratori) Envelliment Trastorns de la cognició Apoptosis Mice (Laboratory animals) Population aging Cognitive psychology |
Issue Date: | 4-Sep-2018 |
Publisher: | MDPI |
Abstract: | Molecular factors involved in neuroprotection are key in the design of novelmultitarget drugs in aging and neurodegeneration. AVCRI104P3 is a huprine derivative that exhibits potent inhibitory effects on human AChE, BuChE, and BACE-1 activities, as well as on AChE-induced and self-induced Abeta aggregation. More recently, cognitive protection and anxiolytic-like effects have also been reported in mice treated with this compound. Now, we have assessed the ability of AVCRI104P3 (0.43 mg/kg, 21 days) to modulate the levels of some proteins involved in the anti-apoptotic/apoptotic processes (pAkt1, Bcl2, pGSK3beta, p25/p35), inflammation (GFAP and Iba1) and neurogenesis in C57BL/6 mice. The effects of AVCRI104P3 on AChE-R/AChE-S isoforms have been also determined. We have observed that chronic treatment of C57BL/6 male mice with AVCRI104P3 results in neuroprotective effects, increasing significantly the levels of pAkt1 and pGSK3beta in the hippocampus and Bcl2 in both hippocampus and cortex, but slightly decreasing synaptophysin levels. Astrogliosis and neurogenic markers GFAP and DCX remained unchanged after AVCRI104P3 treatment, whereas microgliosis was found to be significantly decreased pointing out the involvement of this compound in inflammatory processes. These results suggest that the neuroprotective mechanisms that are behind the cognitive and anxiolytic effects of AVCRI104P3 could be partly related to the potentiation of some anti-apoptotic and anti-inflammatory proteins and support the potential of AVCRI104P3 for the treatment of brain dysfunction associated with aging and/or dementia |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/ijms19092615 |
It is part of: | International Journal of Molecular Sciences, 2018, vol. 19, num. 9, p. 2615 |
URI: | http://hdl.handle.net/2445/127709 |
Related resource: | https://doi.org/10.3390/ijms19092615 |
ISSN: | 1661-6596 |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) Articles publicats en revistes (Institut de Biomedicina (IBUB)) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
681587.pdf | 3.2 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License